Cargando…
Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin
OBJECTIVE: C-reactive protein (CRP) and homocysteine are markers of cardiovascular risk that may have inflammatory effects. HMG coenzyme A reductase inhibitors (statins) have anti-inflammatory effects in vitro, but it is not clear if such responses in vivo are secondary to lipid lowering. We examine...
Autores principales: | Asanuma, Yu, Oeser, Annette, Stanley, Eran, Bailey, David G, Shintani, Ayumi, Stein, C Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817441/ https://www.ncbi.nlm.nih.gov/pubmed/20157364 http://dx.doi.org/10.1111/j.1753-5174.2007.00003.x |
Ejemplares similares
-
Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
por: Drewes, Yvonne M, et al.
Publicado: (2014) -
Endothelial Function in Systemic Lupus Erythematosus: Relationship to Disease Activity, Cardiovascular Risk Factors, Corticosteroid Therapy, and Coronary Calcification
por: Turner, Elizabeth, et al.
Publicado: (2005) -
Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022) -
Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019) -
Computation-Aided
Engineering of Cytochrome P450 for
the Production of Pravastatin
por: Ashworth, Mark A., et al.
Publicado: (2022)